Health Care & Life Sciences » Pharmaceuticals | Kukje Pharma Co. Ltd.

Kukje Pharma Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
120,461
122,426
117,637
120,684
123,310
107,681
Cost of Goods Sold (COGS) incl. D&A
73,306
75,868
63,562
67,303
72,092
59,192
Gross Income
47,156
46,558
54,075
53,381
51,218
48,489
SG&A Expense
46,109
47,981
51,977
49,412
48,654
45,202
EBIT
1,047
1,423
2,098
3,969
2,564
3,287
Unusual Expense
-
170
13
454
158
1,292
Non Operating Income/Expense
755
2,715
2,233
128
424
1,609
Interest Expense
1,398
1,379
1,367
1,189
888
901
Pretax Income
522
5,676
1,482
2,515
2,053
2,830
Income Tax
1,150
1,241
4,203
972
1,014
647
Equity in Affiliates
-
-
200
745
-
-
Consolidated Net Income
1,672
6,917
5,884
799
1,039
2,183
Net Income
2,125
6,932
5,943
773
1,092
2,193
Net Income After Extraordinaries
2,125
6,932
5,943
773
1,092
2,193
Net Income Available to Common
2,125
6,932
5,943
773
1,092
2,193
EPS (Basic)
129.08
409.34
345.24
46.15
64.00
125
Basic Shares Outstanding
16
17
17
17
17
18
EPS (Diluted)
129.23
409.27
344.85
46.50
63.64
125.10
Diluted Shares Outstanding
16
17
17
17
17
18
EBITDA
5,124
2,357
5,455
6,856
5,207
6,028
Non-Operating Interest Income
119
11
33
62
111
166
Minority Interest Expense
453
15
58
26
54
10

About Kukje Pharma Co.

View Profile
Address
96-8 Yatap-ro
Seongnam-si GY 13517
Korea, Republic Of
Employees -
Website http://www.kukjepharm.co.kr
Updated 07/08/2019
KUKJE PHARMA Co. Ltd. engages in the manufacture, sale and distribution of pharmaceutical, cosmetics and health care products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antibiotics, and antifungal and antiviral agents. The company was founded on July 27, 1959 and is headquartered in Seongnam-si, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.